15th May 2014 10:16
LONDON (Alliance News) - Hikma Pharmaceuticals PLC on Thursday maintained its revenue growth guidance for 2014, and raised its guidance for operating margin in its Injectibles business, after a strong start to the year. In a statement ahead of the company's annual general meeting Thursday, Read More
